今日已更新 166 条资讯 | 累计 40611 条内容
关于我们

标签:#Health

找到 333 篇相关文章

AI 资讯

I Added a Fourth Model Mid-Run. It Changed What My Field Test Could Prove.

Latest release: v0.2.2 — Aug 29, 2026 I did something I usually try hard not to do in a field test. I changed the design after it had already started. Halfway through validating AdversarialDebate, I realized the model set was too narrow to answer the most important question in the project. So I added a fourth model in the middle of the run. That was messy. It wasted work. It made the corpus inconsistent for a while. It also turned out to be one of the best decisions in the whole release. This post is about a lesson I trust far more now than I did before building this project: a field test is not just there to produce numbers. It is there to reveal whether your experiment can actually answer the question you think it is answering. The Setup I Started With I began with three models: GPT-4o-mini, Gemini 2.5 Flash, and DeepSeek-V3. That gave me three useful pairings — GPT + Gemini, Gemini + DeepSeek, and GPT + GPT as a homogeneous control. Three labs, two regions, one same-model control. Reasonable spread. I ran the small corpus first, just 3 PRs, to validate the pipeline. Pair Small-corpus score Verdict rate Gemini + DeepSeek 0.835 33% GPT + GPT 0.667 33% GPT + Gemini 0.148 0% The diverse pair was ahead. The weak pair was struggling. The homogeneous control was doing something interesting. If I had stopped there, I would have told a clean story — and it would have been the wrong one. The Problem Was Not The Data. It Was The Coverage. The issue was not that the first three models were bad. The issue was that the experiment could only see part of the diversity spectrum. With those three models, the farthest useful pairing I had was US + China. I did not have a genuinely cross-continent pair that could show what happened at the far end of diversity. The test could suggest whether diversity helped. It could not show whether maximum diversity behaved differently from moderate diversity. That is a major blind spot when the whole thesis is about pairing behavior. I needed a f

2026-08-31 原文 →
AI 资讯

“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z

Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "engineering" one, why clinical trials are still brutally expensive, and why he thinks open, shared datasets (not walled-off ones) are what will actually let AI transform medicine.

2026-08-30 原文 →
AI 资讯

A startup claims it’s found a drug to make your blood young

I knew I’d officially become a ‘longevity influencer’ this month when a company called Generation Lab reached out to offer me the chance to write about—and even receive—their new rejuvenation treatment, an injectable combination of two existing drugs which they call 1 Generation. This wasn’t just any antiaging treatment, either. A company fact sheet says that…

2026-08-28 原文 →
AI 资讯

What’s driving Sweden’s startup boom, from Lovable to Legora

Vibe-coding darling Lovable just raised $400 million at a $13.3 billion valuation, roughly doubling its worth in eight months. But Lovable isn’t the only Stockholm startup putting up huge numbers lately — legal AI company Legora and health tech startup Neko Health are right there with it. On this episode of TechCrunch’s Equity podcast, Dominic-Madori Davis is joined by Sophia Bendz, a partner at Cherry Ventures and longtime fixture of Europe’s startup […]

2026-08-27 原文 →
AI 资讯

Your Oura Ring can’t measure what’s going on in your skull

This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life. Opt in for Optimizer here. Oura's getting sued. A recently filed class-action complaint against the smart ring maker alleges that the company has duped customers […]

2026-08-26 原文 →
AI 资讯

Spyware for Babies

The New York Times has a long article ( alt link ) on surveillance systems aimed at babies. They are increasingly using AI. Nanit and its rivals want to own 24/7 health tracking for the sub-four-foot set. And their already astonishing levels of baby data collection are just the beginning. Nanit recently raised $50 million from investors to expand its use of A.I. and use its camera to track speech and language development, motor skills and more, while extending its presence in children’s bedrooms into early adolescence.

2026-08-26 原文 →